炎症因子与急性冠状动脉综合征斑块易损性关系的研究进展
被引量:3
摘要
急性冠状动脉综合征(ACS)是以冠状动脉粥样硬化斑块破裂(rupture)或糜烂(erosion),继发完全或不完全闭塞性血栓形成为病理基础的一组临床综合征。随着ACS发病机制研究的深入,新的心肌损伤标志物也有了进一步的进展。各种炎症标志物,如C-反应蛋白(CRP)、白细胞介素、金属蛋白酶、髓过氧化物酶MPO、CD40/CD40-L、细胞黏附因子(VCAM-1)等被认为与ACS的发生、发展有着密切关系。
出处
《临床医学》
CAS
2012年第11期113-114,共2页
Clinical Medicine
参考文献18
-
1Chierchia SL. Inflammation and acute coronary syndromes [ J ]. Rev Esp Cardiol, 2001,54(10): 1135 -1140.
-
2Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle calls [ J ]. CJm,.,!ation, 2003,108 ( 16 ) : 1930 - 1932.
-
3Hong YJ, Jeong MH,Choi YH,et al. Relation between high-sensitivi- ty C-reactive protein and coronary plaque components in patients with acute coronary syndrome: virtual histology-intravascular ultrasound a- nalysis[ J]. Korean Circ J, 2011,41($) : 440 -446.
-
4Yeh ET. C-reactive protein is an essential aspect of cardiovascular risk factor stratification[ J]. Can J Cardiol, 2004, 20 ( Suppl B) : 93 B - 96B.
-
5Arroyo Espliguero R, Aranzas P, Cosinsales J, et al. C-reactive pro- tein elevation and disease activity in patients with coronary artery dis- ease[J]. EurHeartJ, 2004, 25(5):401-408.
-
6Pawlus J, Holub M, Kozuch M, et al. Serum myeloperuxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease[ J]. Int J Lab Hematol, 2010, 32 (3) : 320 - 328.
-
7Sawicki M, Sypniewska G, Kozinski M, et al. Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes [ J ]. Eur J Clin Invest, 2011,41 (6) : 667 -671.
-
8Alwi I. The cut-off point of interleukin-6 level in acute coronary syn- drome[J]. Acta Med Indones, 2007, 39(4) : 174 -178.
-
9Chen MC, Chen CJ,Yang CH,et al. Interleukin-18 : a strong predic- tor of the extent of coronary artery disease in patients with unstable an- gina[J]. Heart Vessels, 2007, 22(6) : 371 -375.
-
10Blankenberg S, Rupprecht HJ, Bickel C, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angi- na [ J ]. Circulation, 2002,106 ( 1 ) : 24 - 30.
二级参考文献16
-
1Squire IB,Evans J,Ng LL,et al.Plasma MMP-9 and MMP2 following acute myocardial infarction in man:correlation with echocardiographic and neurohumoral parameters of left ventricolar dysfunction[J].J Cardiac Fail,2004,10(4):328-33.
-
2van Hinsbergh VW,Engelse MA,Quax PH.Pericellular proteases in angiogenesis and vasculogenesis[J].Arterioscler Thromb Vasc Biol,2006,26(4):716-28.
-
3Kai H,lkeda H,Yasukawa H,et al.Peripheral blood levels of matrixmetalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes[J].J Am Coll Cardiol,1998,32(2):368-72.
-
4Visse R,Nagase H.Matrix metalloproteinases and tissue inhibitors of metalloproteinases:structure,function,and biochemistry[J].Citc Res,2003,92(8):827-39.
-
5Duyagu H.Zoghi M,Nalbantgil S,et al.High-sensitive C-reactive protein may be an indicator of the development of atberosclerosis in myocardial bridging[J].Int J Cardiol,2008,124(2):267-70.
-
6Stetler-Stevenson WG.Matrix metalloproteinases in angiogenesis:a moving target for therapeutic intervention[J].J Clin Invest,1999,103(9):1237-41.
-
7ACC/AHA.Guideline updates for the management of patients with unstable angina and non-ST segment elevation myocardial infarction[J].Circulation,2002,106(14):1893-900.
-
8The task force on the management of acute myocardial infarction of european society of cardiology.Management of acute myocardial infarction in patients presenting with ST-segment elevation[J].Eur Heart J,2003,24(1):28-66.
-
9Smith SC Jr,Feldman TE,Hirshfeld JW Jr,et al.ACC/AHA/SCAI 2005 guideline update for percutaneons coronary interventionsummary article:a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)[J].Circulation,2006,113 (1):156-75.
-
10Gross J,Lapiere CM.Collagenolytic activity in amphibian tissue:a tissue culture assay[J].Proc Natl Acad Sci USA,1962,48(15):1014-22.
共引文献18
-
1王林军,宋新,侯思南.急性冠状动脉综合征患者可溶性OX40配体与基质金属蛋白酶9的变化[J].中华老年心脑血管病杂志,2010,12(8):751-751. 被引量:1
-
2李科,刘俊明.基质金属蛋白酶-2,-9与冠心病关系的研究进展[J].中国介入心脏病学杂志,2011,19(2):108-111. 被引量:16
-
3赵东明,杨萍,刘国庆,李桦.血清基质金属蛋白酶-9和干扰素-γ在急性冠脉综合征中的作用[J].中国老年学杂志,2011,31(10):1744-1745. 被引量:2
-
4叶广宁,欧家满,黄万里.经皮冠状动脉介入术对血清MMP-9和超敏C-反应蛋白水平的影响[J].中国实用医药,2011,6(36):1-2.
-
5张丹丹,夏文龙,刘强,张大伟,徐晋妉,吴恒芳,陈相健,杨笛.OX40/OX40L逆向信号对小鼠主动脉内皮细胞MMP-9表达及机制的研究[J].南京医科大学学报(自然科学版),2012,32(1):20-25. 被引量:3
-
6刘春丽,蔡辉.动脉粥样硬化斑块不稳定性因素的研究进展[J].实用医学杂志,2012,28(15):2636-2638. 被引量:6
-
7符国平,吴世畅,汪波.心肌梗死患者溶栓前后的多项炎性因子的变化规律研究[J].海南医学院学报,2012,18(11):1608-1610. 被引量:1
-
8孙丽琴,刘先哲.血浆MMP-9浓度在多器官功能障碍综合征中的预警价值研究[J].中国医疗前沿,2012,7(20):1-1.
-
9王俊.奥扎格雷对急性冠脉综合征患者血浆血管性血友病因子含量及金属蛋白酶-9水平的影响[J].实用临床医药杂志,2012,16(23):49-50. 被引量:1
-
10黄文军,刘俊明,高霞,谢伟,李科,王明建,赵亮,邹琦.血清基质金属蛋白酶-2(MMP-2)和MMP-9与急性冠状动脉综合征的相关研究[J].中国循环杂志,2013,28(2):103-106. 被引量:29
同被引文献44
-
1陈燕,陈慧.基质金属蛋白酶-9与易损斑块[J].心血管康复医学杂志,2007,16(1):96-98. 被引量:15
-
2胡大一,柯元南,颜红兵,等.临床冠心病诊断与治疗指南[M].北京:人民卫生出版社,2010:100-109.
-
3陈韵岱.急性冠脉综合征易损斑块的研究进展[J].中国循环杂志,2007,22(5):390-392. 被引量:27
-
4Sung JW,Lee SH,Byrne CD’et al. High-sensitivity C-re-active protein is associated with the presence of coronaryartery calcium in subjects with normal blood pressure butnot in subjects with hypertension [J]. Arch Med Res,2014,45(2).-170-176.
-
5Bhanushali AA’Das BR. Promoter variants in interleukin-6 and tumor necrosis factor alpha and risk of coronaryartery disease in a population from Western India [J]. In-dian J Hum Genet,2013,19(4) :430-436.
-
6Takahashi F, Hasebe N, Kawashima E, et al. Hyperinsulinemia is an independent predictor for complex atherosclerotic lesion of thoracic aorta in non-diabetic patients [J]. Atherosclerosis,2006,187(2) :336 -342.
-
7曹娟,尹长森.老年冠心病血浆抵抗素与胰岛素抵抗相关性[J].实用全科医学,2008,6(3):256-257. 被引量:4
-
8陆卫平,张红,吕述军,李伟.糖尿病肾病大鼠血清hs-CRP水平变化及罗格列酮的干预作用[J].南京医科大学学报(自然科学版),2008,28(4):496-498. 被引量:7
-
9刘军妮,徐冬玲,杜贻萌,蒋卫东,王欣,董兆强,陈良,胡晓波,王光允,许复郁,赵敬杰,郝琳,王群,鹿庆华.脂蛋白相关磷脂酶A_2与兔易损斑块的相关性研究[J].中国病理生理杂志,2010,26(4):669-675. 被引量:14
-
10杜燕宾,李红莉,张建军.易损斑块的血清炎症标志物的研究进展[J].心血管病学进展,2010,31(4):558-562. 被引量:6
引证文献3
-
1陈磊磊,王泽穆,陈波,王连生.血清胆固醇与炎症因子和冠心病斑块稳定性的相关性分析[J].南京医科大学学报(自然科学版),2014,34(9):1224-1227. 被引量:7
-
2王辉宇,赵光煊.胰岛素抵抗与冠心病严重程度关系研究[J].中华实用诊断与治疗杂志,2015,29(7):689-691. 被引量:16
-
3郑俊华,刘艳阳.血清炎性因子与急性冠状动脉综合征易损斑块相关性的研究进展[J].医学综述,2017,23(1):129-133. 被引量:10
二级引证文献33
-
1夏玉东,顾婷婷,顾月星,宋峻,王杰,李林静.脂必泰对冠心病脂质代谢及斑块稳态临床指标的影响[J].南京医科大学学报(自然科学版),2020,40(10):1544-1547. 被引量:3
-
2郝庭峰.探讨瑞舒伐他汀联合氯吡格雷对急性冠脉综合征患者斑块稳定性指标水平的影响[J].航空航天医学杂志,2021,32(12):1418-1420. 被引量:1
-
3刘凤桐.美国大口胭脂鱼及其养殖技术[J].北京水产,2000(1):13-13. 被引量:1
-
4王南丁,王文杰,朱建粉,张慧芳,周煜,雷媛琳,陶涛.芪丹通脉片对动脉粥样硬化小鼠易损斑块及炎性因子的影响[J].四川中医,2019,37(1):75-78. 被引量:10
-
5陈西洲.血清炎症因子在冠心病斑块易损程度的预测价值[J].中国临床医生杂志,2015,43(9):41-43. 被引量:15
-
6付刚,夏豪.胰岛素抵抗与相关生化指标及冠心病危险因素的相关性[J].西南国防医药,2016,26(10):1164-1167. 被引量:3
-
7马国锋,武向阳,王雅宁,黎军德.心复宁V号联合西医药物治疗对冠心病心绞痛患者血清血黏度、脂质代谢及斑块稳定性的影响[J].海南医学院学报,2016,22(21):2577-2580. 被引量:8
-
8罗先虎.胰岛素抵抗与心脑血管疾病关系研究进展[J].中国当代医药,2016,23(35):22-24. 被引量:1
-
9李松,江倩,彭丹,覃松柏,王永贞.冠心病患者胰岛素抵抗程度的影响因素分析[J].现代生物医学进展,2017,17(7):1294-1296. 被引量:3
-
10万启军,张颖,杨悌.多囊卵巢综合征患者抗苗勒氏管激素、睾酮和胰岛素抵抗相关性的临床研究[J].中国血液流变学杂志,2017,27(3):320-322. 被引量:4
-
1陈英,段小嬿,吴相慰,张树锋.短期大剂量普伐他汀对急性心肌梗死患者CRP和MMP-9、CD40L的影响[J].广西医科大学学报,2013,30(3):386-388. 被引量:1
-
2底胜峰,张莉,王瑜玲,杜洪淼.测定结核性和恶性胸腔积液E-选择素水平的临床意义[J].临床荟萃,2006,21(19):1415-1415. 被引量:1
-
3霍丽梅,宋光耀,叶蔚.脂联素与动脉粥样硬化[J].心血管病学进展,2005,26(3):299-302. 被引量:15
-
4董记华,朱淑敏,赵燕平.慢性阻塞性肺疾病与细胞黏附因子2和尾加压素Ⅱ的关系及意义[J].医学综述,2009,15(19):3022-3023.
-
5李越凡,王艳丽.心可舒治疗不稳定心绞痛疗效观察[J].中国社区医师(医学专业),2006,8(15):64-64. 被引量:2
-
6田新利,李俊峡.急性冠脉综合征双联抗血小板治疗与上消化道出血[J].中国循证心血管医学杂志,2013,5(3):215-216. 被引量:10
-
7徐乐超,李云英.PGE_1对糖尿病肾病血清黏附因子和Ⅳ型胶原的影响[J].山东医学高等专科学校学报,2007,29(6):409-411.
-
8胡轶,王凯旋.化脑患者脑脊液TNF-α、IL-6、sICAM-1联检的临床意义[J].放射免疫学杂志,2006,19(3):218-219. 被引量:2
-
9周玉杰,杨士伟.急性冠脉综合征抗栓与溶栓治疗[J].临床药物治疗杂志,2009,7(3):12-16.
-
10陈欣,王琳,杨汉东,闵新文.缬沙坦对炎性动脉粥样硬化的影响[J].实用医学杂志,2006,22(13):1491-1493. 被引量:6